We are live on ! Find out more
Russell Investments Group

Russell Investments Group Portfolio holdings

AUM $114B
1-Year Est. Return 41.71%
This Fund
S&P 500
This Quarter Est. Return
+10.82%
1 Year Est. Return
+41.71%
3 Year Est. Return
+123.74%
5 Year Est. Return
+158.32%
10 Year Est. Return
AUM
$48.6B
AUM Growth
+$3.08B
Cap. Flow
+$3.24M
Cap. Flow %
0.01%
Top 10 Hldgs %
13.89%
Holding
3,030
New
136
Increased
1,065
Reduced
1,247
Closed
140

Sector Composition

Rank Sector Weight
1 Technology 18.34%
2 Healthcare 14.16%
3 Financials 13.97%
4 Real Estate 9.14%
5 Consumer Discretionary 9.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZYME icon
2551
Zymeworks
ZYME
$1.75B
$111K ﹤0.01%
14,144
-39,611
-74% -$278K
AKBA icon
2552
Akebia Therapeutics
AKBA
$245M
$111K ﹤0.01%
191,983
-3,932
-2% -$1.23K
DBD
2553
DELISTED
Diebold Nixdorf Incorporated
DBD
$110K ﹤0.01%
77,700
-14,739
-16% -$31.6K
LBC
2554
DELISTED
Luther Burbank Corporation Common Stock
LBC
$110K ﹤0.01%
+9,900
New +$116K
SPNS
2555
DELISTED
Sapiens International
SPNS
$110K ﹤0.01%
5,932
NVAX icon
2556
Novavax
NVAX
$1.3B
$110K ﹤0.01%
10,654
+6,520
+158% +$115K
ATLC icon
2557
Atlanticus Holdings
ATLC
$1.43B
$108K ﹤0.01%
4,128
CDLX icon
2558
Cardlytics
CDLX
$24.1M
$107K ﹤0.01%
+1,860
New +$115K
ESPR
2559
DELISTED
Esperion Therapeutics
ESPR
$107K ﹤0.01%
+17,252
New +$123K
FWONA icon
2560
Liberty Media Series A
FWONA
$24B
$107K ﹤0.01%
2,092
+769
+58% +$39.1K
MMSI icon
2561
Merit Medical Systems
MMSI
$5.38B
$107K ﹤0.01%
1,510
PETS icon
2562
PetMed Express
PETS
$41.9M
$106K ﹤0.01%
5,981
NCNO icon
2563
nCino
NCNO
$2.04B
$105K ﹤0.01%
3,990
-61,159
-94% -$1.72M
MOFG
2564
DELISTED
MidWestOne Financial Group
MOFG
$105K ﹤0.01%
3,300
SMG icon
2565
ScottsMiracle-Gro
SMG
$3.59B
$104K ﹤0.01%
2,136
-1,341
-39% -$67.2K
ALGT icon
2566
Allegiant Air
ALGT
$2.34B
$103K ﹤0.01%
1,522
FNWB icon
2567
First Northwest Bancorp
FNWB
$108M
$103K ﹤0.01%
6,736
BCBP icon
2568
BCB Bancorp
BCBP
$158M
$103K ﹤0.01%
5,700
+2,400
+73% +$44.9K
MCRB icon
2569
Seres Therapeutics
MCRB
$46.6M
$102K ﹤0.01%
915
CURO
2570
DELISTED
CURO Group Holdings Corp.
CURO
$101K ﹤0.01%
28,333
-121,004
-81% -$461K
CBT icon
2571
Cabot Corp
CBT
$4.46B
$101K ﹤0.01%
1,504
-15,282
-91% -$1.07M
JBI icon
2572
Janus International
JBI
$664M
$100K ﹤0.01%
+10,500
New +$101K
BWFG icon
2573
Bankwell Financial Group
BWFG
$546M
$99.8K ﹤0.01%
+3,391
New +$101K
KEN icon
2574
Kenon Holdings
KEN
$3.57B
$98K ﹤0.01%
+2,967
New +$107K
SNFCA icon
2575
Security National Financial
SNFCA
$245M
$97.7K ﹤0.01%
16,276

Similar funds

Russell Investments Group's Q4 2022 Portfolio in Review

As of Q4 2022, Russell Investments Group held 3,030 positions worth $48.6B, up 6.8% from $45.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Russell Investments Group's Q4 2022 filing shows 136 new, 1,065 increased, 1,247 reduced and 140 closed positions. Its largest new stake was Sabre Corporation 6.50% Series A Mandatory Convertible Preferred Stock: 940,000 shares worth $791K. The largest sale was Duke Realty Corp., an estimated $109M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.

  • Russell Investments Group's largest Q4 2022 buy was Sabre Corporation 6.50% Series A Mandatory Convertible Preferred Stock: 940,000 shares worth $791K.
  • Russell Investments Group added most to Bank of America Series L in Q4 2022, an estimated $806M increase.
  • Russell Investments Group's biggest Q4 2022 reduction was Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A, cutting an estimated $80.1M.
  • Russell Investments Group fully exited Duke Realty Corp. in Q4 2022, selling an estimated $109M.
  • Russell Investments Group's ten largest holdings make up 14% of its $48.6B portfolio in Q4 2022.
  • Russell Investments Group opened 136 new positions and closed 140 in Q4 2022.
  • Russell Investments Group's portfolio value rose 6.8% quarter-over-quarter to $48.6B.

Based on Russell Investments Group's 13F filing for Q4 2022, filed 8 Feb 2023.